SentinelOne Stock Correction Overdone as Singularity Platform Drives Steady Growth

SentinelOne Stock Correction Overdone as Singularity Platform Drives Steady Growth

SentinelOne (S) stock has performed poorly over the past 52 weeks with a decline of nearly 10% over the period. This slow performance can be attributed to results that have disappointed markets even as the industry’s outlook remains bright. For the first quarter of fiscal 2027, SentinelOne marginally missed revenue estimates, while second-quarter guidance missed…

Read More
Investors are fleeing to South Korea and Taiwan ETFs to diversify. If you do that, you’ll still be chasing AI chip stocks.

Investors are fleeing to South Korea and Taiwan ETFs to diversify. If you do that, you’ll still be chasing AI chip stocks.

Every time the US stock market gets heavier, the Wall Street marketing machine kicks into high gear. The cycle returns to a favorite narrative: geographic diversification. Retail investors are urged to ditch their concentrated domestic stocks and buy single-country ETFs to capture untapped and uncorrelated growth cycles abroad. More Barchart news There is no crystal…

Read More
Linde plc (LIN) rose as investors favor its defensive business profile

Linde plc (LIN) rose as investors favor its defensive business profile

Impax Asset ManagementA London-based investment management firm, specializing in sustainable investments, published its Q1 2026 investor letter for its “Impax Global Environmental Markets Fund.” A copy of the letter is available to download here. The Fund held its own during the quarter by outperforming its main benchmark, the MSCI ACWI Index. Stock selection in Information…

Read More
Is CVS Health Stock Outperforming the S&P 500?

Is CVS Health Stock Outperforming the S&P 500?

CVS Health Corporation (CVS) is a leading provider of health solutions, including healthcare and retail pharmacy services. With a market capitalization of $115.6 billion, the company offers prescription drugs, beauty, personal care, cosmetics and healthcare products, as well as pharmacy benefit management (PBM), disease management and administrative services. Companies worth $10 billion or more are…

Read More